Usana Health Sciences
USNA
147 hedge funds and large institutions have $403M invested in Usana Health Sciences in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 23 closing their positions.
32% more call options, than puts
Call options by funds: $140K | Put options by funds: $106K
2.11% more ownership
Funds ownership: 53.72% → 55.83% (+2.1%)
2% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 54
5% less funds holding
Funds holding: 154 → 147 (-7)
13% less capital invested
Capital invested by funds: $463M → $403M (-$59.7M)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$3.16M |
| 2 |
Pzena Investment Management
New York
|
+$3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.97M |
| 4 |
N
Numerai
San Francisco,
California
|
+$2.78M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.48M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.36M |
| 3 |
Charles Schwab
San Francisco,
California
|
-$1.23M |
| 4 |
Renaissance Technologies
New York
|
-$1.23M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.12M |
USNA Hedge Fund Activity: Q3 2024 in Review
147 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2024, worth a combined $403M — down 13% from $463M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of USNA and 16 opened new positions — a net loss of 7 holders — while 54 trimmed existing stakes and 53 added.
The largest buyer was Pacer Advisors, adding an estimated $3.16M. The largest seller was JP Morgan Chase, cutting an estimated $1.48M.
- 147 institutional investors held Usana Health Sciences (USNA) as of Q3 2024, down from 154 in Q2 2024.
- Funds reported $403M of Usana Health Sciences stock for Q3 2024, down 13% quarter-over-quarter.
- 16 funds opened new Usana Health Sciences positions in Q3 2024 and 23 closed out, a net change of -7 holders.
- The largest Usana Health Sciences buyer in Q3 2024 was Pacer Advisors, an estimated $3.16M added.
- The largest Usana Health Sciences seller in Q3 2024 was JP Morgan Chase, an estimated $1.48M sold.
Based on aggregated 13F filings for Q3 2024.